p38 Mitogen-activated protein kinase signaling regulates streptococcal M1 protein-induced neutrophil activation and lung injury
Related Experiment Video
Updated: May 28, 2026

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
Published on: December 15, 2014
Songen Zhang1, Milladur Rahman, Su Zhang
1Section for Surgery, Malmö University Hospital, Malmö, Sweden.
Abstract:
M1 serotype of Streptococcus pyogenes can cause STSS and acute lung damage. Herein, the purpose was to define the role of p38 MAPK signaling in M1 protein-induced pulmonary injury. Male C57BL/6 mice were treated with specific p38 MAPK inhibitors (SB 239063 and SKF 86002) prior to M1 protein challenge. Edema, neutrophil infiltration, and CXC chemokines were determined in the lung, 4 h after M1 protein administration. Flow cytometry was used to determine Mac-1 expression. Phosphorylation and activity of p38 MAPK were determined by immunoprecipitation and Western blot. IVM was used to analyze leukocyte-endothelium interactions in the pulmonary microcirculation. M1 protein challenge increased phosphorylation and activity of p38 MAPK in the lung, which was inhibited by SB 239063 and SKF 86002. Inhibition of p38 MAPK activity decreased M1 protein-induced infiltration of neutrophils, edema, and CXC chemokine formation in the lung, as well as Mac-1 up-regulation on neutrophils. IVM showed that p38 MAPK inhibition reduced leukocyte rolling and adhesion in the pulmonary microvasculature of M1 protein-treated mice. Our results indicate that p38 MAPK signaling regulates neutrophil infiltration in acute lung injury induced by streptococcal M1 protein. Moreover, p38 MAPK activity controls CXC chemokine formation in the lung, as well as neutrophil expression of Mac-1 and recruitment in the pulmonary microvasculature. In conclusion, these findings suggest that targeting the p38 MAPK signaling pathway may open new opportunities to protect against lung injury in streptococcal infections.
Insights
p38 MAPK signaling drives lung injury from Streptococcus pyogenes M1 protein by increasing neutrophil infiltration and edema. Inhibiting this pathway may protect against severe streptococcal lung damage.
Area of Science:
- Immunology
- Molecular Biology
- Pathology
Background:
- Streptococcus pyogenes M1 serotype is a significant cause of streptococcal toxic shock syndrome (STSS) and acute lung injury.
- The precise molecular mechanisms underlying M1 protein-induced pulmonary damage require further elucidation.
Purpose of the Study:
- To investigate the role of p38 mitogen-activated protein kinase (MAPK) signaling in M1 protein-mediated acute lung injury.
- To determine if p38 MAPK inhibition can mitigate M1 protein-induced pulmonary pathology.
Main Methods:
- Mice were treated with p38 MAPK inhibitors (SB 239063, SKF 86002) before M1 protein challenge.
- Lung injury parameters (edema, neutrophil infiltration, CXC chemokines) and neutrophil Mac-1 expression were assessed.
- p38 MAPK phosphorylation and activity were measured via immunoprecipitation and Western blot.
- Intravital microscopy (IVM) evaluated leukocyte-endothelium interactions in pulmonary microcirculation.
Main Results:
- M1 protein challenge activated p38 MAPK in the lung, an effect blocked by inhibitors.
- p38 MAPK inhibition significantly reduced neutrophil infiltration, edema, and CXC chemokine levels.
- Inhibition decreased Mac-1 expression on neutrophils and reduced leukocyte rolling and adhesion in pulmonary microvasculature.
Conclusions:
- p38 MAPK signaling is a key regulator of neutrophil recruitment and infiltration in M1 protein-induced acute lung injury.
- p38 MAPK activity influences CXC chemokine production and neutrophil-endothelial interactions within the lung.
- Targeting the p38 MAPK pathway presents a potential therapeutic strategy for lung injury associated with streptococcal infections.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
Inflammation
Acute Inflammation III: Local and Systemic Effects
Acute Inflammation I: Inflammatory Response
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

